TiGenix NV has announced the appointment of Jean Stéphenne as an independent director and new chairman of the company’s board of directors. Mr Stéphenne was until recently a member of the corporate executive team at GlaxoSmithKline Plc and chairman and president of GSK Biologicals in Belgium.
TiGenix, a regenerative medicines company, has also appointed Russell Greig as an independent director. Mr Greig was previously president of SR One, GSK’s corporate venture capital arm. Dr Greig currently serves as chairman of AM Pharma in the Netherlands; Isconova AB in Sweden; and Syntaxin Ltd in the UK.
TiGenix announced the appointments on 20 September 2012.
Copyright 2012 Evernow Publishing Ltd